Literature DB >> 17659976

Ocular involvement as the initial manifestation of T-cell chronic lymphocytic leukemia.

Carmen J Calfa1, Izidore S Lossos, Phillip Ruiz, Janet L Davis.   

Abstract

PURPOSE: To present a case of T-cell chronic lymphocytic leukemia (T-CLL) manifesting as an intraocular lymphoma.
DESIGN: Interventional case report.
METHODS: We performed a vitreous biopsy in a 67-year-old woman who presented with blurred vision and vitreous cellular infiltration. Morphologic, immunohistochemical, flow cytometry, and molecular analysis by polymerase chain reaction of vitreous fluid, peripheral blood, bone marrow aspirate, and biopsy were performed.
RESULTS: Cytofluorographic and molecular analysis of vitreous cells demonstrated a monoclonal T-cell population consistent with a T-cell intraocular lymphoma. Systemic evaluation established diagnosis of T-cell CLL.
CONCLUSION: T-CLL is a rare disease with an aggressive clinical course. We present a case of T-cell intraocular lymphoma as the initial manifestation of an otherwise asymptomatic T-CLL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17659976     DOI: 10.1016/j.ajo.2007.03.031

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Diagnosis of systemic metastatic retinal lymphoma.

Authors:  Xiaoguang Cao; Defen Shen; David G Callanan; Manabu Mochizuki; Chi-Chao Chan
Journal:  Acta Ophthalmol       Date:  2011-03       Impact factor: 3.761

2.  A Case of Early Ocular Manifestation of Maculopathy in a 37 year Old Male Patient of CLL.

Authors:  Syed Riaz Mehdi; Nishi Tandon; Sufia Ahmad Khan; Sharique Ahmad
Journal:  Indian J Hematol Blood Transfus       Date:  2014-05-11       Impact factor: 0.900

3.  Evaluation of the reactive T-cell infiltrate in uveitis and intraocular lymphoma with flow cytometry of vitreous fluid (an American Ophthalmological Society thesis).

Authors:  Janet L Davis; Philip Ruiz; Milan Shah; Efrem D Mandelcorn
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.